Severe Acute Respiratory Syndrome Coronavirus 2 is a new coronavirus that causes the illness COVID-19. Researchers have established via relevant data that multi-organ destruction, cytokine storm, and lymphocytopenia induced by SARS-CoV-2 are the primary causes of severe illness and patient mortality in COVID-19 patients. And now, as we pass into a new phase, regulatory changes in many nations will cause there to be a shift in the focus of additional research input from the clinical period to the numerous challenges encountered by patients following recovery. We must cope with the growing number of COVID-19 patients who, even after the infection has healed, continue to face functional impairment in their day-to-day life as well as a wide range of long-term symptoms. Their sickness may seriously affect their capacity to carry out the activities of daily living, which will have a detrimental influence on their quality of lives. In addition, lymphopenia has been found to be equally present in these patients recovering from COVID-19 who have undergone the effects of Long-Covid. This study aims to evaluate if the existence of lymphopenia in COVID-19-recovering patients impacts the durability of COVID-19 symptoms by examining individuals with lymphopenia and post-COVID-19 conditions. The purpose of the study is to assess if individuals with lymphocytopenia are more likely than those without lymphocytopenia to be exposed to long-COVID symptoms after eight months.